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Background: The cognitive status is generally considered as a major determinant
of rehabilitation outcome in Parkinson’s disease (PD). No studies about the effect of
cognitive impairment on motor rehabilitation outcomes in PD have been performed
before.
Objective: This study is aimed to evaluate the impact of cognitive decline on
rehabilitation outcomes in patients with PD.
Methods: We retrospectively identified 485 patients with PD hospitalized for a
4-week Multidisciplinary Intensive Rehabilitation Treatment (MIRT) between January
2014 and September 2015. According to Mini Mental State Examination (MMSE),
patients were divided into: group 1—normal cognition (score 27–30), group 2—mild
cognitive impairment (score 21–26), group 3—moderate or severe cognitive impairment
(score ≤ 20). According to Frontal Assessment Battery (FAB), subjects were divided into
patients with normal (score ≥13.8) and pathological (score <13.8) executive functions.
The outcome measures were: Unified Parkinson’s Disease Rating Scale (UPDRS),
Parkinson’s Disease Disability Scale (PDDS), Six Minutes Walking Test (6MWT), Timed
Up and Go Test (TUG) and Berg Balance Scale (BBS).
Results: All scales had worse values with the increase of cognitive impairment
and passing from normal to pathological executive functions. After rehabilitation, all
the outcome measures improved in all groups (p < 0.0001). Between groups, the
percentage of improvement was significantly different for total UPDRS (p = 0.0009,
best improvement in normal MMSE group; p = 0.019, best improvement in normal
FAB group), and BBS (p < 0.0001, all pairwise comparisons significant, best
improvement in patients with worse MMSE score; p < 0.0001, best improvement in
patients with pathological FAB). TUG (p = 0.006) and BBS (p < 0.0001) improved
in patients with pathological FAB score, more than in those with normal FAB score.
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Conclusions: Patients gain benefit in the rehabilitative outcomes, regardless of
cognition. Our data suggest that rehabilitation could be effective also in Parkinsonian
subjects with cognitive impairment, as well as with dysexecutive syndrome.
Keywords: Parkinson’s disease, neurorehabilitation, cognitive impairment, dysexecutive syndrome, learning
INTRODUCTION
Evenwith optimal pharmacological or surgical therapies, patients
with Parkinson’s disease (PD) experience disabling symptoms
(such as postural instability or freezing of gait) that do
not respond to these treatments. Exercise is considered a
possible, complementary treatment for PD (Clark et al., 1956)
and recent studies showed benefits of different rehabilitative
approaches on the progression of motor decay (Goodwin et al.,
2008; Keus et al., 2009; Frazzitta et al., 2012, 2015b). Due
to the loss of dopamine in the dorsolateral striatum, the
basal ganglia region associated with the control of habitual
motor behaviors, PD patients present an impaired ability
to acquire and express automatic actions (Redgrave et al.,
2010). Nevertheless, even if implicit learning mechanisms
are defective in Parkinsonian patients in comparison to
normal subjects, motor learning is feasible in PD (Nieuwboer
et al., 2007) and this is crucial for rehabilitation. In this
context, literature data indicate that training the patients
to use cognitive strategies allows the execution of correct
movements (Morris et al., 2009) under executive/volitional
control.
Many PD patients present cognitive dysfunctions and the
cognitive status is considered an important determinant of
rehabilitation outcomes (Abbruzzese et al., 2016). However,
in elderly patients with impaired cognition the effect of
rehabilitation has been addressed before and several authors
found that poor cognitive status does not hamper the
outcomes of rehabilitative efforts (Diamond et al., 1996;
Colombo et al., 2004; Heyn et al., 2004; Poynter et al.,
2013). Poynter et al. (2013) in an observational study of
241 patients demonstrated that even patients with moderate
cognitive impairment were able to make significant gains
in grooming, dressing, toileting, transferring and mobility
(as measured with Barthel Index Score) after rehabilitation
treatment. Similarly, a study performed in a geriatric
rehabilitation unit, on a large population, found no correlation
between Mini Mental State Examination (MMSE) score and
functional status on admission and demonstrated functional
and clinical gains in Barthel Index Score for individuals
through the full range of MMSE score (Colombo et al.,
2004).
Even if this issue is very important in order to optimize the
rehabilitative care, there are no data concerning the relation
between cognition and rehabilitative outcome in PD.
Moving from the clinical practice with inpatient subjects
with PD, in this retrospective study, we evaluated whether the
cognitive decline affects the outcomes of an intensive, aerobic




PD patients were retrospectively identified from our Department
of Parkinson’s disease, Movement Disorders and Brain Injury
Rehabilitation (‘‘Moriggia-Pelascini’’ Hospital—Gravedona
ed Uniti, Como, Italy). Between June 2014 and September
2015 we hospitalized 752 patients suffering from different
movement disorders for a 4-week Multidisciplinary Intensive
Rehabilitation Treatment (MIRT; Frazzitta et al., 2012, 2013,
2015b,c). Amongst all, we excluded subjects suffering from
atypical parkinsonisms (59), vascular parkinsonism (87),
iatrogenic parkinsonism (10), previous stroke (7) and
hydrocephalus (4). Fourty six subjects were excluded
for their concomitant diagnosis of major depression or
clinically significant psychiatric disorders. Moreover, 31
patients were excluded due to uncertain diagnosis and 23 did
not complete the rehabilitative treatment for intercurrent
medical conditions. Finally, we identified 485 subjects
with PD. Parkinsonian patients were diagnosed according
to the UK Brain Bank criteria (Hughes et al., 1992) and
were evaluated at the beginning and at the end of the
rehabilitation treatment by neurologists and physiotherapists
with expertise in movement disorders field. The study
design and protocol were approved by the local Scientific
Committee (‘‘Moriggia-Pelascini’’ Hospital, Gravedona ed
Uniti—Como, Italy) and were in accordance with the code
of Ethics of the World Medical Association (Declaration
of Helsinki, 1967). All patients included in the study had
previously given consent to use their clinical data for scientific
purposes. For those patients with MMSE score <24 the
informed consent had been obtained in the presence of
relatives.
Cognitive Evaluation
At the admission, a Neuropsychologist assessed the cognitive
profile using the MMSE and the Frontal Assessment Battery
(FAB). The tests were performed in the morning, during
the medication ‘‘on’’ state. MMSE is a tool for screening
of cognitive impairment (Folstein et al., 1975). According
to MMSE normative data (Measso et al., 1993) patients
were divided into three groups: Group 1 (MMSE 27–30,
normal cognition), Group 2 (MMSE 21–26, mild cognitive
impairment), Group 3 (MMSE≤20, moderate or severe cognitive
impairment). These cut-off scores were defined as per the
UK National Institute for Clinical Excellence guidelines for
classifying cognitive impairment (National Collaborating Centre
for Mental Health (UK), 2007). The FAB evaluates frontal
lobe dysfunctions (Dubois et al., 2000). According to FAB
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normative data (Appollonio et al., 2005) patients were divided
into two groups: normal executive functions (FAB ≥13.8) and
pathological executive functions (FAB <13.8).
Rehabilitation Treatment
MIRT (Frazzitta et al., 2012, 2013, 2015b,c) is an intensive,
aerobic and goal-based rehabilitation treatment, designed in
accordance with the literature indications. All the activities
included in the protocol are performed with a heart rate
reserve comprised between 70 and 80%. It consists of a
4-week physical therapy, in a hospital setting, which entails
four daily sessions for 5 days and 1 h of physical exercise
on the sixth day. The duration of each session, including
recovery periods, is about 1 h. The first session consists
of a one-to-one session with physical therapist: it comprises
cardiovascular warm-up activities, relaxation, muscle-stretching
exercises to improve the range of motion of spinal, pelvic
and scapular joints, exercises to improve the functionality
of the abdominal muscles, postural changes and exercises
specifically addressed to improve balance and postural control.
The second session exploits the use of different devices
to improve gait and balance: a stabilometric platform with
visual cues (patients had to follow a pathway on a screen
by using a cursor sensitive to their feet movements on
the platform), treadmill plus (treadmill training with visual
cues and auditory feedbacks; Frazzitta et al., 2009), crossover
(Frazzitta et al., 2015a) and cycloergometer. The maximum
speed of treadmill scrolling is 3.5 Km/h. The selection of
the devices to adopt and the training parameters setting are
defined for each patient in relation to the disease severity.
The third is a session of occupational therapy to improve
autonomy in everyday activities. The last session includes
1 h of speech therapy. On the sixth day patients are
trained for 1 h using the devices. The rehabilitation program
is personally tailored and could include: hydrokinesitherapy
(for patients with severe balance and postural problems),
robotic-assisted walking training for complex gait disorders,
virtual-reality training and psychoeducational groups with
neuropsychologists.
Outcome Measures
Clinical, functional and motor scores were assessed at baseline
and after 4 weeks by neurologists and physiotherapists with
expertise in movement disorders field. All evaluations were
performed in the morning, 1 h after taking drugs. The assessment
included: Unified Parkinson’s Disease Rating Scale (UPDRS),
Parkinson’s Disease Disability Scale (PDDS), Six Minutes
Walking Test (6MWT), Timed Up and Go Test (TUG) and Berg
Balance Scale (BBS).
Statistical Analysis
The Shapiro–Wilk statistic was used to test the normality of
the distribution of all variables. Most outcome variables were
non-normally distributed, with severe violations to the normality
assumption for BBS and TUG. Hence, to test whether the
effectiveness of rehabilitation was dependent on the level of
cognitive state (normal or impaired) at baseline, we considered
the difference in outcome variables between the discharge
and admission values and run a one-factor non-parametric
analysis of variance (ANOVA) (Kruskal-Wallis) on the cognition
factor (three groups for MMSE and two groups for FAB).
The same analysis was carried out both on absolute and
percentage differences, since both measurements provide useful
and complementary clinical information. Between- and within-
group comparisons were performed by the Kruskal-Wallis
test and Wilcoxon signed-rank test, respectively. Following a
significant result for Kruskal-Wallis test, pairwise differences in
groups were analyzed by Dunn’s test (Dunn, 1964). Comparisons
of categorical variables were carried out with the Chi-square
test.
The association between variables was assessed by Spearman’s
rank correlation coefficient.
Since a certain degree of association between cognitive
state and age, years of education and Hoehn and Yahr
(H&Y) was expected, multivariable regression methods
were used to investigate whether changes in outcome
variables were associated with cognitive state after adjustment
for these covariates. Descriptive statistics for continuous
variables are reported as median (lower quartile, upper
quartile). Descriptive statistics for categorical variables
are reported as percentage frequency. All statistical tests
were two-tailed and statistical significance was set at
p < 0.05. All analyses were carried out using the SAS/STAT
statistical package, release 9.2 (SAS Institute Inc., Cary, NC,
USA).
RESULTS
Out of 485 PD patients, according to MMSE, 236 had normal
cognition (mean ± SD: 28.7 ± 1.1), 208 had mild cognitive
impairment (24.8 ± 1.6) and 41 were moderately or severely
cognitively impaired (17.7 ± 3.1). Considering FAB, 255
patients had normal executive functions (16.0 ± 1.4) and
230 had pathological executive functions (10.4 ± 2.6).
Correlation between MMSE and FAB values was good
(r = 0.63, p < 0.0001). Considering categorized values,
only one patient out of the 41 with MMSE ≤20 (moderately or
severely cognitively impaired) had normal executive functions
(FAB ≥13.8). MMSE scores were negatively related to age
(R = −0.38, p < 0.0001) and H&Y (R = −0.24, p < 0.0001)
and positively related to years of education (R = 0.15,
p = 0.0007). Similarly, FAB scores were negatively related
to age (R = −0.35, p < 0.0001) and H&Y (R = −0.26
p < 0.0001) and positively related to years of education
(R= 0.14, p= 0.002).
Patients Grouped by MMSE
Table 1 reports demographical and clinical data of patients
subdivided according to MMSE.
Passing from MMSE 27–30 to MMSE 21–26 and MMSE
≤20, age and H&Y significantly increased as the MMSE
was lower (p < 0.0001 both) and years of education
decreased (p = 0.0031), while no difference was observed
Frontiers in Aging Neuroscience | www.frontiersin.org 3 August 2016 | Volume 8 | Article 192
Ferrazzoli et al. Cognition and Rehabilitation in Parkinson’s Disease
TABLE 1 | Demographical and clinical data of patients subdivided according to MMSE.
MMSE 27–30 (GROUP 1) MMSE 21–26 (GROUP 2) MMSE ≤ 20 (GROUP 3)
Age 65.0 (59.0, 73.0) 71.0 (67.0, 75.0) 75.0 (70.0, 78.3)
Education (years) 11.0 (8.0, 13.0) 10.0 (5.0, 13.0) 8.0 (5.0, 13.0)
H&Y scale 2.5 (2.0, 3.0) 3.0 (2.5, 3.0) 3.0 (3.0, 4.0)
L-dopa equivalent dose 617.5 (395.0, 850.0) 656.0 (430.0, 872.5) 695.0 (500.0, 830.0)
Sex (% Male) 52 61 56
Most affected side (% right) 55 50 63
Abbreviations: MMSE, Mini Mental State Examination; H&Y, Hoehn and Yahr; L-dopa, Levodopa.
in levodopa equivalent dose (p = 0.448). No relationships
between baseline score on the MMSE and sex or the
most affected side were found (p = 0.15 and p = 0.28
respectively).
Figures 1A–G reports admission and discharge values for all
outcome variables, with differences (discharge-admission) and
percentage change, for every MMSE group.
At admission, all scales had worse values passing from
MMSE 27–30 to MMSE 21–26 and MMSE ≤20 (total
UPDRS, UPDRS II, UPDRS III, PDDS, 6MWT, BBS and
TUG: p < 0.0001). Pairwise comparisons by Dunn’s test
showed that all paired differences were significant. After
rehabilitation, all scales improved significantly in each group
of patients (p < 0.0001 all variables in all groups). To
assess whether the degree of improvement was different
between groups, the percentage improvements in outcome
variables were compared. Significant differences were observed
for the changes in total UPDRS (p = 0.0009, no pairwise
significant differences and best improvements in patients with
normal MMSE score), PDDS (p = 0.025, with significant
differences between MMSE ≤20 and MMSE 27–30 and
best improvements in patients with normal MMSE score),
UPDRS III (p = 0.0041, with significant differences between
MMSE ≤20 and MMSE 27–30 and MMSE 21–26 and
MMSE 27–30 and best improvement in group 1 or 2), BBS
(p < 0.0001, all pairwise comparisons significant and best
improvement in patients with moderate or severe cognitive
impairment).
For the remaining outcome variables, namely UPDRS II,
6MWT and TUG no between groups significant differences were
observed in the percentage changes (p = 0.211, p = 0.159,
p= 0.277, respectively).
Patients Grouped by FAB
The same analysis was carried out dividing patients according
to FAB. Table 2 reports basal values for demographical and
clinical variables in patients with normal executive functions
(FAB ≥13.8) and pathological executive functions (FAB <13.8).
Passing from normal to pathological executive functions,
age and H&Y significantly increased (p < 0.0001 both), years
of education decreased (p = 0.0009), while no difference was
observed in levodopa equivalent dose (p = 0.073). No different
distribution of sex and most affected side was found (p = 0.290
and p= 0.840 respectively).
Figures 2A–G reports admission and discharge values for all
outcome variables, with differences and percentage change, for
both groups.
At admission, all scales had worse values passing from
normal to pathological executive functions (total UPDRS,
UPDRS II, UPDRS III, PDDS, 6MWT, BBS and TUG:
p < 0.0001). After rehabilitation, all scales improved
significantly in both groups (p < 0.0001 all variables in
both groups). Comparing the percentage improvements in
outcome variables in the two groups, significant differences
were observed only for changes in total UPDRS (p = 0.019,
best improvement in patients with normal FAB score),
BBS and TUG (p < 0.0001 and p = 0.006 respectively,
best improvement in patients with pathological FAB
score).
Finally, no significant difference in the percentage changes
was observed for UPDRS III, UPDRS II, 6MWT and PDDS,
(p = 0.111, p = 0.103, p = 0.06 and p = 0.432 respectively),
indicating a similar beneficial effect of rehabilitation in the two
groups as assessed by these outcome variables.
Role of Covariates
Since age, H&Y and education were strongly related to
cognition status, we also investigated the relationship between
improvement in outcome variables and cognition status
after correction for these covariates. Considering patients
grouped according to MMSE, only percentage changes
in total UPDRS and BBS remained significantly different
between the three groups after correction (p = 0.04 and
p = 0.008 respectively), while considering patients grouped
according to FAB no percentage changes remained significantly
different between the two groups after correction. However,
these significant differences don’t appear to have clinical
relevance.
DISCUSSION
This is the first study that addresses the issue of the
relationships between cognitive impairment and rehabilitative
outcome in PD patients. As opposed to what is normally
believed (Abbruzzese et al., 2016), our data demonstrates that
also individuals with cognitive impairment treated with a
specific, intensive rehabilitative approach were able to gain
comparable benefits in motor and functional outcomes as
patients without cognitive impairment. Since there are several
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FIGURE 1 | Admission, discharge and delta (discharge-admission) for all the outcome variables in patients grouped according to MMSE: (A) Total
UPDRS, (B) UPDRS III, (C) UPDRS II, (D) 6MWT, (E) BBS, (F) TUG, (G) PDDS. Data are reported as median (box), lower and upper quartile (whiskers). The
percentage value of delta is reported in brackets. The p values are pertaining to the comparison discharge vs. admission. Abbreviations: MMSE, Mini Mental State
Examination; UPDRS, Unified Parkinson’s Disease Rating Scale; 6MWT, Six Minutes Walking Test; BBS, Berg Balance Scale; TUG, Timed Up and Go Test; PDDS,
Parkinson’s Disease Disability Scale.
PD patients with cognitive deficits, it is important to re-
examine the question of rehabilitative care also for these
subjects. In our patients, age, severity of disease (evaluated
with H&Y scale) and cognition (evaluated with MMSE and
FAB) were correlated with each other: higher age and more
advanced motor disturbances were associated with poorer
cognitive performances. In accordance with literature data
(Kuzis et al., 1999; Appollonio et al., 2005), MMSE and FAB
scores showed a direct relation with years of education and
an inverse relation with age. In all groups, no differences were
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TABLE 2 | Demographical and clinical data of patients subdivided
according to FAB.
FAB ≥ 13.8 FAB < 13.8
Age 66.0 (59.0, 72.0) 71.0 (67.0, 77.0)
Education (years) 12.0 (8.0, 13.0) 8.0 (5.0, 13.0)
H&Y scale 2.5 (2.0, 3.0) 3.0 (2.5, 3.0)
L-Dopa equivalent dose 600.0 (392.5, 850.0) 665.0 (458.8, 876.3)
Sex (% Male) 54 58
Most affected side (% right) 53 54
Abbreviations: FAB, Frontal Assessment Battery; H&Y, Hoehn and Yahr; L-Dopa,
Levodopa.
found in the total amount of levodopa dose. This finding
allows us to exclude a secondary, dose-dependent effect of
dopaminergic therapy on rehabilitative outcomes. According
to the patients’ subdivision on the basis of MMSE score,
we observed that the three groups differ at the baseline in
all scales. These differences have a relation with cognition:
with the worsening of MMSE score, the performances get
worse. This finding could be explained with the worsening of
performances as age increases or with the existence of a direct
relation between cognition and motor skills. However, even
after correction for age, disease severity and years of education,
cognitively impaired patients obtain significant benefits after
rehabilitation.
Since PD patients frequently suffer from dysexecutive
syndrome, we evaluated also the impact of this condition
on rehabilitation subdividing patients on the basis of FAB
score. Even in this case, in the group with pathological
score the performances at baseline were worse and both
groups improved in all scales after rehabilitation. Moreover,
data concerning the improvement obtained in TUG and BBS
score by patients with dysexecutive syndrome has a very
important clinical relevance: these patients had pathological
scores at admission and get normal performances after
the treatment (Qutubuddin et al., 2005; Nocera et al.,
2013).
We found that rehabilitation is effective in PD patients
with cognitive impairment, as much as in those with normal
cognition. Indeed, even if the percentage improvement in total
UPDRS was significantly greater in patients with preserved
cognition, all groups showed a significant improvement after
rehabilitation.
Our findings could indicate that even in presence of
cognitive decline, the ability to learn is not completely hindered.
We argue that our intensive and goal-based rehabilitation
treatment, entailing constant and repetitive exercises, exploits
both the implicit and the explicit learning. Implicit learning
is the acquisition of knowledge without awareness and
volition (Reber, 1989) and differs from explicit learning,
defined as a form of conscious and intentional process of
knowledge acquisition (Cohen et al., 1985). Striatum plays a
central role in implicit learning (Gamble et al., 2014), the
anterior cingulate/mesial prefrontal cortex supports the explicit
component of learning, whereas hippocampus is crucial for both
explicit and implicit processes (Gamble et al., 2014). People
with PD have degeneration of dopamine-producing neurons,
leading to dopamine deficiency, striatal deficits and consequent
impairment in implicit learning (Rieckmann et al., 2010;
Gamble et al., 2014). Moreover, several studies demonstrated
that patients suffering from PD with dementia have deficits
on tasks of explicit learning as well as on some task of
implicit learning (Bondi and Kaszniak, 1991; Kuzis et al.,
1999).
It is conceivable that the proposed treatment is able to
optimize motor learning both explicit, exploiting the acquisition
of voluntary strategies, and implicit through incremental
stimulus-response associations.
Therefore, MIRT probably works through the interaction
between implicit and explicit learning mechanisms. This
interaction was theorized and described previously: Destrebecqz
et al. (2005) found that anterior cingulate/mesial prefrontal
cortex exerts control on the activity of the striatum and suggested
the existence of a functional interaction between different brain
regions that subtend different computational objectives and in
which information processing appears to be either accompanied
by awareness (the anterior cingulate/mesial prefrontal cortex) or
not (the striatum).
Probably, other mechanisms underlie the improvement
we found after the treatment. In particular, with respect
to walking, spinal mechanisms that are not influenced by
cognition could be implicated. It has been postulated that
treadmill training could provide adequate sensory inputs,
which may stimulate the spinal locomotor circuitry (Van
de Crommert et al., 1998). Certainly, treadmill-plus through
the use of feedbacks and cues optimize learning. However,
the belt of the treadmill itself forces the subject to step,
through stretch facilitation of hip flexors and ankle plantar
flexors and provides adequate sensory inputs which stimulates
the spinal locomotor circuitry, stressing the functioning of
the Central Pattern Generator (Bello and Fernandez-Del-
Olmo, 2012). Beyond these mechanical concepts, Edgerton
et al. (1991) provided evidence that different strategies,
including treadmill training, could produce functional changes
or ‘‘motor learning’’ properly in the spinal motor-generating
circuitry.
Finally, we found better percentage of improvement in
TUG and BBS in patients with pathological FAB score.
Dysexecutive syndrome negatively affects those motor
performances that entail a high degree of executive components,
like TUG and BBS. Since any task that involves planning
and executing a goal-directed action requires executive
functions (Morris et al., 2001), we explain these results
hypothesizing that MIRT leads to an improvement in these
scales through the voluntary/attentive application of learned
motor skills.
There are some limitations to this study: first, we did
not perform a detailed assessment of neuropsychological
functions. This would allow us to understand better the
cognitive profile of patients and evaluate this in relation to the
rehabilitative outcomes. We did not consider the aspect of the
generalization of learned abilities. Further studies should explore
how patients with and without cognitive decline transfer the
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FIGURE 2 | Admission, discharge and delta (discharge-admission) for all the outcome variables in patients grouped according to frontal assessment
battery (FAB): (A) Total UPDRS, (B) UPDRS III, (C) UPDRS II, (D) 6MWT, (E) BBS, (F) TUG, (G) PDDS. Data are reported as median (box), lower and upper
quartile (whiskers). The percentage value of delta is reported in brackets. The p values are pertaining to the comparison discharge vs. admission. Abbreviations:
MMSE, Mini Mental State Examination; UPDRS, Unified Parkinson’s Disease Rating Scale; 6MWT, Six Minutes Walking Test; BBS, Berg Balance Scale; TUG, Timed
Up and Go Test; PDDS, Parkinson’s Disease Disability Scale.
effect of the treatment in daily life and the duration of the
obtained benefits over time. Moreover, different rehabilitation
approaches have been proposed for patients with PD: in
this study we evaluated only the efficacy of an intensive
and goal-based treatment. This is not enough to affirm that
is possible to achieve the same results with other, different
Frontiers in Aging Neuroscience | www.frontiersin.org 7 August 2016 | Volume 8 | Article 192
Ferrazzoli et al. Cognition and Rehabilitation in Parkinson’s Disease
rehabilitation approaches. Further studies are needed to clarify
this issue.
CONCLUSION
We demonstrated for the first time that PD patients in
early, medium and advanced stages of disease with cognitive
dysfunctions, who undergo a specific treatment exploiting
implicit learning strategies, are able to gain benefit in
rehabilitative outcomes. Our data allow challenging the belief
that rehabilitation should be reserved only for patients with
normal cognition.
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